Toward alpha‐synuclein seed amplification assay in clinical practice

Abstract INTRODUCTION Seed amplification assays (SAAs) demonstrate remarkable diagnostic performance in alpha‐synucleinopathies. However, existing protocols lack accessibility in routine laboratories, mainly due to the requirement for in‐house production of recombinant alpha‐synuclein (aSyn). This s...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mathieu Verdurand, Flora Kaczorowski, Sophie Dautricourt, Virginie Desestret, Maïté Formaglio, Hélène Mollion, Gil Petitnicolas, Ali Afifi, Anthony Fourier, Antoine Garnier‐Crussard, Isabelle Quadrio
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-01-01
Col·lecció:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Matèries:	alpha‐synuclein (α‐synuclein) aSyn biomarker brain homogenate (BH) cerebrospinal fluid (CSF) dementia with Lewy bodies (DLB)
Accés en línia:	https://doi.org/10.1002/dad2.70066
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!